Sabra Healthcare REIT (NASDAQ:SBRA) Issues Earnings Results, Misses Expectations By $0.05 EPS

Sabra Healthcare REIT (NASDAQ:SBRA) announced its quarterly earnings results on Monday. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.05), FiscalAI reports. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The firm had revenue of $249.57 million for the quarter, compared to analysts’ expectations of $236.64 million. During the same period in the previous year, the company earned $0.38 EPS. The company’s quarterly revenue was up 31.4% on a year-over-year basis.

Sabra Healthcare REIT Price Performance

Shares of SBRA stock opened at $19.72 on Tuesday. The stock has a market cap of $5.04 billion, a price-to-earnings ratio of 75.85, a PEG ratio of 1.73 and a beta of 0.63. The business’s fifty day moving average is $19.86 and its 200 day moving average is $19.96. Sabra Healthcare REIT has a twelve month low of $17.53 and a twelve month high of $22.77. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95.

Analysts Set New Price Targets

Several research firms recently issued reports on SBRA. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Weiss Ratings lowered Sabra Healthcare REIT from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Truist Financial lifted their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Finally, Raymond James Financial raised Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Seven investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $21.50.

Sabra Healthcare REIT News Roundup

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Sabra reported third-quarter earnings of $0.41 per diluted share, exceeding the consensus estimate of $0.16 and rising from $0.38 in the year-ago quarter. Revenue increased 31.4% year over year to $249.6 million, ahead of the $236.6 million analyst estimate. Earnings Flash
• Positive Sentiment: Key REIT performance measures were solid: third-quarter FFO was $0.40 per share, normalized FFO was $0.39, AFFO was $0.45 and normalized AFFO was $0.41. FFO surpassed the $0.40 consensus estimate and increased from $0.38 a year earlier. Sabra Tops Q3 FFO and Revenue Estimates
• Positive Sentiment: Management raised 2026 EPS guidance to $1.54-$1.55, above the $1.52 consensus forecast. The higher outlook may support investor confidence in operating performance and cash-generation prospects. Sabra Reports Third Quarter 2026 Results and Updates Guidance
• Positive Sentiment: Sabra also declared its quarterly dividend, reinforcing the stock’s income appeal for REIT investors. Sabra Reports Results and Declares Dividend
• Neutral Sentiment: Despite the earnings beat and improved guidance, the shares were little changed, suggesting investors may have largely anticipated the strong results or remain focused on REIT-specific factors such as interest rates, leverage and healthcare-property risks.

Insider Transactions at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the firm’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the transaction, the chief executive officer owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.09% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.